COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,388 Articles (22,816 medRxiv, 8,572 bioRxiv)

Most recent first Previous |  Page 2161: Articles 21601-21610  | Next

Percentage HScore confirms low incidence of secondary haemophagocytic lymphohistiocytosis in hospitalised COVID-19 patients
Ardern-Jones, M. R., Stammers, M., Phan, H. T. T., Borca, F., Koutalopoulou, A., Teo, Y., Batchelor, J., Smith, T., Duncombe, A.
10.1101/2020.10.19.20214015 — Posted: 2020-10-21
Accuracy of Healthcare Professionals Nasopharyngeal Swab Technique in SARS-CoV-2 Specimen Collection
Woods, R., Walsh, M., Nwaokorie, K., Crowley, J., Lacy, P., de Barra, E.
10.1101/2020.10.19.20213140 — Posted: 2020-10-21
Low-Cost Manually Assembled Open Source Reader for Isothermal Pathogen Detection from Saliva using RT-LAMP: SARS-CoV-2 Use Case
Bramley, J. C., Waligorski, J. E., Kremitzki, C. K., Liebeskind, M. J., Yenkin, A., Xu, E., Lalli, M. A., O'Halloran, J. A., Mudd, P. A., House, S., Mitra, R., Milbrandt, J. D., Buchser, W. J.
10.1101/2020.10.19.20215319 — Posted: 2020-10-21
A placebo-controlled double blind trial of hydroxychloroquine in mild-to-moderate COVID-19
Dubee, V., Roy, P.-M., Vielle, B., Parot-Schinkel, E., Blanchet, O., Darsonval, A., Lefeuvre, C., Abbara, C., Boucher, S., Devaud, E., Robineau, O., Rispal, P., Guimard, T., D'Anglejan, E., Diamantis, S., Custaud, M.-A., Pellier, I., Mercat, A.
10.1101/2020.10.19.20214940 — Posted: 2020-10-21 Discussion: Onsite
Dietary Nicotianamine as a Factor in International Variations of Mortality from Covid-19
Day, C. E.
10.1101/2020.10.15.20213470 — Posted: 2020-10-20
Viral surface geometry shapes influenza and coronavirus spike evolution
Amitai, A.
10.1101/2020.10.20.347641 — Posted: 2020-10-20
Impact of clade specific mutations on structural fidelity of SARS-CoV-2 proteins
Basu, S., Mukhopadhyay, S., Das, R., Mukhopadhyay, S., Singh, P. K., Ganguli, S.
10.1101/2020.10.20.347021 — Posted: 2020-10-20
Single-cell RNA-sequencing reveals dysregulation of molecular programs associated with SARS-CoV-2 severity and outcomes in patients with chronic lung disease
Bui, L. T., Winters, N. I., Chung, M.-I., Joseph, C., Gutierrez, A. J., Habermann, A. C., Adams, T. S., Schupp, J. C., Poli, S., Peter, L. M., Taylor, C. J., Blackburn, J. B., Richmond, B. W., Nicholson, A. G., Rassl, D., Wallace, W. A., Rosas, I. O., Jenkins, R. G., Kaminski, N., Kropski, J. A., Banovich, N. E., Human Cell Atlas Lung Biological Network
10.1101/2020.10.20.347187 — Posted: 2020-10-20
High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples
Anand, S. P., Prevost, J., Richard, J., Perreault, J., Tremblay, T., Drouin, M., Fournier, M.-J., Lewin, A., Bazin, R., Finzi, A.
10.1101/2020.10.20.346783 — Posted: 2020-10-20
Isolation of cross-reactive monoclonal antibodies against divergent human coronaviruses that delineate a conserved and vulnerable site on the spike protein
Wang, C., van Haperen, R., Gutierrez-Alvarez, J., Li, W., Okba, N., Albulescu, I., Widjaja, I., van Dieren, B., Fernandez-Delgado, R., Sola, I., Hurdiss, D., Daramola, O., Grosveld, F., van Kuppeveld, F., Haagmans, B., Enjuanes, L., Drabek, D., Bosch, B.-J.
10.1101/2020.10.20.346916 — Posted: 2020-10-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).